Daniel William F 4
4 · Horizon Therapeutics Public Ltd Co · Filed May 12, 2021
Insider Transaction Report
Form 4
Daniel William F
Director
Transactions
- Exercise/Conversion
Common Stock
2021-05-10$12.70/sh+20,000$254,000→ 20,000 total - Sale
Common Stock
2021-05-10$86.56/sh−19,834$1,716,831→ 166 total - Sale
Common Stock
2021-05-10$87.01/sh−166$14,444→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-10+20,000→ 13,286 totalExercise: $12.70Exp: 2024-09-18→ Ordinary Shares (20,000 underlying)
Holdings
- 74,467(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.00 to $87.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The stock option vested in 36 equal monthly installments following the date of grant.